Metric Finance
LearnFAQ
LearnFAQ

Learn / JANX

NASDAQ: JANX

Janux Therapeutics (JANX) stock, explained like you're 5

Janux Therapeutics trades on the Nasdaq under the ticker JANX. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 1.1 billion dollars.

Ticker
JANX
Exchange
Nasdaq
Sector
Healthcare
Industry
Pharmaceutical Preparations
Size
Small cap, about 1.1 billion dollars

Is Janux Therapeutics a small, medium or large cap company?

No. Janux Therapeutics is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 1.1 billion dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Janux Therapeutics makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves JANX stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • Janux Therapeutics, Inc. (JANX) Stock Price, News, Quote & History (Yahoo! Finance Canada)
  • Janux Therapeutics, Inc. (JANX) stock price, news, quote and history (Yahoo Finance UK)
  • $JANX stock is up 7% today. Here's what we see in our data. (Quiver Quantitative)
  • Janux Therapeutics, Inc. (JANX) stock price, news, quote and history (Yahoo Finance Singapore)
  • Janux Therapeutics (JANX), What Is Drawing Fresh Attention Now? (Yahoo Finance)

Follow JANX in your daily brief

Each trading day at 5 PM ET we post what happened to Janux Therapeutics and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow JANX

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about Janux Therapeutics stock

What does Janux Therapeutics do?

Janux Therapeutics trades on the Nasdaq under the ticker JANX. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 1.1 billion dollars.

What is the ticker symbol for Janux Therapeutics?

Janux Therapeutics trades under the ticker JANX on the Nasdaq.

What is Janux Therapeutics's market cap?

Janux Therapeutics is a small cap stock with a market cap of about 1.1 billion dollars.

How does Janux Therapeutics make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves JANX stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow JANX stock every day?

Add JANX to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow JANX daily

A free brief on Janux Therapeutics and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • NVS · Novartis AG
  • AZN · Astrazeneca PLC
  • NVO · Novo Nordisk A S
  • VRTX · Vertex Pharmaceuticals Inc / Ma

Similar stocks

  • NVSNovartis AG
  • AZNAstrazeneca PLC
  • NVONovo Nordisk A S
  • VRTXVertex Pharmaceuticals Inc / Ma

Compare JANX: JANX vs NVS, JANX vs AZN, JANX vs NVO

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed